These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 31065671)
1. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin. Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia. Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337 [TBL] [Abstract][Full Text] [Related]
3. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells. Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831 [TBL] [Abstract][Full Text] [Related]
4. Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer. Zhang J; Ying Y; Li M; Wang M; Huang X; Jia M; Zeng J; Ma C; Zhang Y; Li C; Wang X; Shu XS Theranostics; 2020; 10(22):10016-10030. PubMed ID: 32929331 [TBL] [Abstract][Full Text] [Related]
5. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells. Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs. Mathur R; Sehgal L; Havranek O; Köhrer S; Khashab T; Jain N; Burger JA; Neelapu SS; Davis RE; Samaniego F Haematologica; 2017 Feb; 102(2):373-380. PubMed ID: 27742770 [TBL] [Abstract][Full Text] [Related]
7. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts. Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567 [TBL] [Abstract][Full Text] [Related]
8. Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin. He C; Sun J; Liu C; Jiang Y; Hao Y Clin Epigenetics; 2019 Jan; 11(1):8. PubMed ID: 30651137 [TBL] [Abstract][Full Text] [Related]
9. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism. Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118 [TBL] [Abstract][Full Text] [Related]
11. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent. Dalpatraj N; Naik A; Thakur N Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737 [TBL] [Abstract][Full Text] [Related]
12. A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer. Deng X; Kong F; Li S; Jiang H; Dong L; Xu X; Zhang X; Yuan H; Xu Y; Chu Y; Peng H; Guan M Cell Death Dis; 2021 May; 12(5):485. PubMed ID: 33986248 [TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286 [TBL] [Abstract][Full Text] [Related]
14. β-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo. Deng M; Yan P; Gong H; Li G; Wang J Mol Med; 2024 Jun; 30(1):95. PubMed ID: 38910244 [TBL] [Abstract][Full Text] [Related]
15. Histone H3 lysine 27 trimethylation acts as an epigenetic barrier in porcine nuclear reprogramming. Xie B; Zhang H; Wei R; Li Q; Weng X; Kong Q; Liu Z Reproduction; 2016 Jan; 151(1):9-16. PubMed ID: 26515777 [TBL] [Abstract][Full Text] [Related]
16. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays. Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714 [TBL] [Abstract][Full Text] [Related]
17. Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo. Wen S; Wang J; Liu P; Li Y; Lu W; Hu Y; Liu J; He Z; Huang P Cancer Lett; 2018 Jan; 413():35-45. PubMed ID: 29069576 [TBL] [Abstract][Full Text] [Related]
19. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice. Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation. Kania AK; Guo M; Scharer CD; Boss JM Immunohorizons; 2021 Dec; 5(12):918-930. PubMed ID: 34880105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]